IFC, a member of the World Bank Group, is providing a debt financing package to Hikma Pharmaceuticals to help ensure smooth deliveries of medicines across the Middle East and North Africa amid the COVID-19 pandemic. The $200 million package is…
Recognizing the importance of millennials in shaping today’s business environment, Hikma Pharmaceuticals created a board that translates their ideas into action. By Dina Al-Wakeel Lana Ghanem is the Managing Director of Hikma Ventures—the corporate venture capital arm of Hikma Pharmaceuticals—and head…
Brands of Jordan Part 2 Hikma Pharmaceuticals What is it? Hikma Pharmaceuticals is one of the top pharmaceutical brands in the region. Headquartered in London, the company specializes in developing, manufacturing, and marketing a broad range of injectables, branded pharmaceuticals,…
Endeavor Jordan held its fourth annual DealMakers event in Amman last month, once again providing some of the region’s top entrepreneurs and investors with the opportunity to meet face-to-face. The event was attended by 62 entrepreneurs, representing some of the…
After finding success locally, Jordanian skincare company Pella Pharmaceuticals is now aiming to expand further into foreign markets with its Derma product line. By Rebecca Irvine The pharmaceutical industry in Jordan is a strong one. You only need to look…
Hikma Pharmaceuticals plans to inject $30 million into digital health startups through a new global investment fund. By Rebecca Irvine Until March Hikma was a FTSE100 listed company, and remains the biggest pharmaceutical company in the Middle East. Now making a…
Mazen Darwazeh: Vice-Chairman and MENA CEO of Hikma Date of Interview: October 2013 Hikma is one of a handful of Jordanian companies that can truly be considered world class. In the first half of 2013, its revenues reached $638.3 million….
Want to keep on top of your health but don’t know where to start? These four health and fitness apps will help keep you fit and healthy, and ready to deal with any medical issues that come your way. By…
In a move that is set to transform its position in the US generics market, Hikma Pharmaceuticals has announced that it is acquiring Roxane Laboratories for JD1.88 billion ($2.65 billion) in cash and stock. Hikma, which was one of a number…
While Jordan isn’t lacking in creative talent, attracting investment for media and art business ventures is no easy task. In order to grow the Kingdom’s creative economy, an industry body is needed to fight its corner, said Ali al-Husry, chairman…